HCA Healthcare (NYSE:HCA) Announces Earnings Results

HCA Healthcare (NYSE:HCA) issued its earnings results on Friday. The company reported $6.22 EPS for the quarter, topping the consensus estimate of $6.03 by $0.19, RTT News reports. HCA Healthcare had a return on equity of 520.98% and a net margin of 8.52%. During the same quarter in the prior year, the company posted $5.90 earnings per share. HCA Healthcare updated its FY 2025 guidance to 24.050-25.850 EPS.

HCA Healthcare Stock Down 1.6 %

HCA stock opened at $320.24 on Friday. HCA Healthcare has a twelve month low of $279.93 and a twelve month high of $417.14. The company has a quick ratio of 1.00, a current ratio of 1.12 and a debt-to-equity ratio of 48.71. The stock’s 50 day moving average is $314.50 and its 200-day moving average is $352.84. The firm has a market capitalization of $81.12 billion, a PE ratio of 14.37, a P/E/G ratio of 1.09 and a beta of 1.64.

Analyst Ratings Changes

Several analysts recently weighed in on the company. Raymond James cut HCA Healthcare from an “outperform” rating to a “market perform” rating in a report on Friday, November 22nd. Truist Financial dropped their price objective on HCA Healthcare from $430.00 to $390.00 and set a “buy” rating for the company in a report on Monday, January 6th. Wells Fargo & Company cut HCA Healthcare from an “equal weight” rating to an “underweight” rating and lowered their price target for the stock from $400.00 to $320.00 in a report on Monday, November 25th. StockNews.com downgraded HCA Healthcare from a “strong-buy” rating to a “buy” rating in a research report on Monday, November 4th. Finally, Cantor Fitzgerald reiterated an “overweight” rating and issued a $392.00 target price on shares of HCA Healthcare in a research report on Tuesday, October 1st. One equities research analyst has rated the stock with a sell rating, three have given a hold rating, twelve have issued a buy rating and two have issued a strong buy rating to the company’s stock. According to MarketBeat, HCA Healthcare currently has an average rating of “Moderate Buy” and an average target price of $385.27.

Insider Activity

In related news, insider Erol R. Akdamar sold 2,900 shares of HCA Healthcare stock in a transaction on Thursday, November 14th. The stock was sold at an average price of $353.00, for a total transaction of $1,023,700.00. Following the sale, the insider now directly owns 6,843 shares in the company, valued at approximately $2,415,579. This trade represents a 29.76 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, SVP Phillip G. Billington sold 3,897 shares of HCA Healthcare stock in a transaction on Thursday, November 14th. The stock was sold at an average price of $350.00, for a total value of $1,363,950.00. Following the sale, the senior vice president now owns 52,702 shares in the company, valued at $18,445,700. This trade represents a 6.89 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Corporate insiders own 1.60% of the company’s stock.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.